HealthCor Management’s Insulet PODD Stock Holding History

HealthCor Management’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,150	Closed	-$1.56M	–	66
2022 Q2	$1.56M	Buy	+7,150	New	+$1.63M	0.16%	49

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management's PODD Position: Q3 2022 in Review

HealthCor Management sold out of Insulet (PODD) in Q3 2022, closing a stake of 7,150 shares — an estimated $1.56M sold.

HealthCor Management first reported a position in PODD in Q2 2022 and held it in 1 quarter. The position peaked at $1.56M in Q2 2022. 468 funds tracked by Wall St. Rank hold PODD as of Q3 2022.

HealthCor Management reported no remaining Insulet position as of Q3 2022 after selling out during the quarter.
HealthCor Management sold 7,150 Insulet shares in Q3 2022, an estimated $1.56M.
HealthCor Management first reported a position in Insulet in Q2 2022 and held it in 1 quarter.
HealthCor Management's Insulet position peaked at $1.56M in Q2 2022.
468 funds tracked by Wall St. Rank held Insulet as of Q3 2022.

Based on HealthCor Management's 13F filing for Q3 2022, filed 14 Nov 2022.